Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) announced a dividend on Wednesday, October 18th, NASDAQ reports. Shareholders of record on Monday, October 16th will be paid a dividend of 1.5118 per share on Friday, October 20th. The ex-dividend date is Friday, October 20th. Talaris Therapeutics Price Performance Shares of Talaris Therapeutics stock opened at […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) announced a dividend on Tuesday, October 10th, NASDAQ reports. Investors of record on Monday, October 16th will be given a dividend of 1.5118 per share on Friday, October 20th. The ex-dividend date is Friday, October 20th. Talaris Therapeutics Price Performance Talaris Therapeutics stock opened at $2.69 on […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily volume of 629,200 shares, […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 12,942 shares of the company’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $2.49, for a total value of $32,225.58. Following the sale, the director now owns 3,771,392 shares in the company, valued at approximately […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 16,870 shares of the business’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $2.59, for a total transaction of $43,693.30. Following the completion of the sale, the director now owns 3,798,542 shares in the company, […]